// App-Quantinova.ai

1182 : Heparin-binding epidermal growth factor-like growth factor is a pro-differentiating factor in neuroblastoma

Researchers

Presenter

  • Angela L. Gaviglio

Principal Investigators

  • Gerard C. Blobe

Medical Centers

  • Duke University, Durham, NC

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Neuroblastoma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved